Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas

Epilepsia

Volumn 38, Issue 3, 1997, Pages 334-337

  Masereel, B ^a   Lambert, D M ^b   Dogne J M ^a   Poupaert, J H ^b   Delarge, J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Anticonvulsant; BM 34; Epilepsy; Sulfonylthiourea; Sulfonylurea

Indexed keywords

BM 11; BM 27; BM 34; N [(4 CYCLOHEPTYLAMINOPYRID 3 YL)SULFONYL] N' CYCLOHEPTYLUREA; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; ELECTRIC SHOCK; EPILEPSY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; DIURETICS; EPILEPSY; MALE; MICE; NEUROPROTECTIVE AGENTS; SEIZURES; SULFONAMIDES; SULFONYLUREA COMPOUNDS; THIOUREA;

EID: 0030898303     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb01125.x     Document Type: Article

References (19)

1. + cotransporter. Eur J Med Chem 1994;29:527-35.
2. Schlatter E, Greger R, Weidtke C. Effect of "high ceiling" diuretics active on salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney. Eur J Physiol 1983;396:210-7.
3. Winner M, Di Stefano A, Wangemann P, Delarge J, Liègeois JF, Greger R. Analogues of torasemide: structure function relationships - experiments in the thick ascending limb of the loop of Henle of rabbit nephron. Eur J Physiol 1987;408:54-62.
4. Hochman DW, Baraban SC, Owens JW, Scwatzkroin PA. Dissociation of synchronization and excitability in furosemide blockage of epileptiform. Science 1995;270:99-102.
5. Loscher W, Honack D. Over additive anticonvulsam effect of memantine and NBQX in kindled rats. Eur J Pharmacol 1994;259:R3-5.
6. Loscher W, Wlaz P, Rundfeldt C, Baran H, Honack D. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br J Pharmacol 1994;112:97-106.
7. Smith SE, Al Zuibaidy ZA, Champan AG, Meldrum BS. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. Epilepsy Res 1993;15:101-11.
8. Namba T, Morimoto K, Yamada N, Otsuki S. Antiepileptic action of 7-chlorokinurenic acid on amygdala kindling of rats. Pharmacol Biochem Behav 1993;46:275-81.
9. Smith SE, Chapman AG. Acute and chronic anticonvulsam effects of D(-) CPPene in genetically epilepsy-prone rats. Epilepsy Res 1993;15:193-9.
10. Cloux JL, Grammen J, Delarge J, Pirad ML, Thunus L. Tentative de détermination de la constante fragmentaire (f) du groupement sulfonylurée. J Pharm Belg 1988;43:141-51.
11. + cotransporter: in vitro study. J Pharm Pharmacol 1992;44:589-93.
12. Litchfield JT,Wilcoxon F. A simplified method of evaluating doseeffects experiments. J Pharmacol Exp Ther 1949;96:99-102.
13. Czuczwar SJ, Frey HH, Löscher W. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur J Pharmacol 1984;108:273-80.
14. Porter RJ, Cereghino JJ, Gladding GD, et al. Antiepileptic Drug Development Program. Cleve Clin Q 19984;51:293-305.
15. Dunham NW, Miya TA. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 1957;46:208-9.
16. Audus KL, Chikhale PJ, Miller DW, Thompson SE, Borchardt RT. Brain uptake of drugs: the influence of chemical and biological factors. In: Testa B, ed. Advances in drug research. Vol 23. New York: Academic Press, 1992:1-64.
17. Masereel B, Schynts M, Krzesinski JM, Pirotte B, Rorive G, Delarge J. A sulphonylthiourea (BM 20) related to torasemide, a new loop diuretic with relative potassium-sparing properties. J Pharm Pharmacol 1993;45:720-8.
18. Bailleux V, Vallée L, Nuyts JP, et al. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)-phtalimide and prototype antiepileptic drugs in mice and rats. Epilepsia 1995;36:559-65.
19. Aganval SP, Black MI. Determination of the pKa′ value for 5,5 diphenylhydantoin. J Pharm Sci 1968;57:1434-5.